Adaptin Bio (APTN) EPS (Basic) (2023 - 2026)
Adaptin Bio (APTN) posted EPS (Basic) of -$0.13 for Q1 2026, up 24.79% sequentially from -$0.18 in Q4 2025, and down 27.26% YoY from -$0.18 in Q1 2025.
Adaptin Bio (APTN) EPS (Basic) (2023 - 2026) Analysis & Trends
Adaptin Bio has reported EPS (Basic) for 4 years, with the latest figure at -$0.13 in Q1 2026.
- Quarterly EPS (Basic) fell 27.26% year-over-year to -$0.13 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.66 (down 13.69% YoY) and the FY2025 annual result came in at -$0.52, down 6.9% from the prior year.
- EPS (Basic) grew to -$0.13 in Q1 2026 per APTN's latest filing, from -$0.18 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.01 in Q3 2023 and troughed at -$0.22 in Q3 2024.
- A 4-year average of -$0.13 and a median of -$0.16 in 2024 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) plunged 2479.42% in 2024, then advanced 10.54% in 2025.
- Over 4 years, EPS (Basic) stood at -$0.01 in 2023, then tumbled by 1098.94% to -$0.17 in 2024, then declined by 4.95% to -$0.18 in 2025, then grew by 24.79% to -$0.13 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.13, -$0.18, and -$0.2 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.14 |
| Mar 31, 2026 | -0.13 |
| Dec 31, 2025 | -0.18 |
| Sep 30, 2025 | -0.20 |
| Jun 30, 2025 | -0.18 |
| Mar 31, 2025 | -0.10 |
| Dec 31, 2024 | -0.17 |
| Sep 30, 2024 | -0.22 |
| Jun 30, 2024 | -0.16 |
| Mar 31, 2024 | -0.07 |
| Dec 31, 2023 | -0.01 |
| Sep 30, 2023 | -0.01 |